Figure 5
From: Novel CMKLR1 Inhibitors for Application in Demyelinating Disease

SAR of α-NETA analogs for CMKLR1 inhibition. Thin arrows indicate structural features leading to increased potency.
From: Novel CMKLR1 Inhibitors for Application in Demyelinating Disease

SAR of α-NETA analogs for CMKLR1 inhibition. Thin arrows indicate structural features leading to increased potency.